BV Investment Partners Announces Majority Investment in The Millennium AllianceRead More

Overview

The pharma value chain has always been complex with long development cycles, fragmented data across functions, and decisions that carry enormous scientific and commercial stakes. AI promised to change this, but the path from that promise to production has been blocked by the same foundational problem: data that is not unified, trusted, or AI-ready to act on.

The enterprises pulling ahead are not the ones with the most data. They are the ones that have built a semantic understanding of it, connecting clinical, regulatory, commercial, and operational intelligence into one coherent foundation that agents can reason on and act from.

This is what Agentifying the pharma value chain looks like in practice:

  • Building a trusted enterprise AI foundation that delivers a single source of truth across R&D, supply chain, and commercial functions.
  • Moving from AI that surfaces insights to AI that takes action, autonomously driving biomarker discovery, rebalancing supply networks, and orchestrating personalized commercial engagement at scale.
  • Governing agentic AI in a regulated life sciences environment without slowing down innovation.
  • Translating AI investments into measurable outcomes across the molecule-to-market journey.

Blackbarn

New York City

Objectives

STRATEGICALLY CURATING

like-minded leaders in a relaxed but focused manner

CREATING AN ENVIRONMENT

conducive for you to establish powerful connections

IDENTIFYING NEW OPPORTUNITIES

to ensure your brand sustains its competitive advantage

Roundtable Discussions

During the Dinner you will participate in an interactive roundtable discussion of your choosing. Below is the topic:

  • Molecule to Market: Agentifying the Pharma Value Chain

Dinner Format

  • Cocktails & Networking
  • Welcome Address
  • Fireside Chat & Panel Session
  • Dinner and Roundtable Discussions
  • Dessert & Round-Robin

Tredence is a global AI and data science solutions provider focused on solving the last-mile problem in AI, the gap between insight creation and value realization. Tredence leverages deep domain expertise, advanced data platforms and accelerators, and strategic partnerships to provide tailored, cutting-edge solutions to its clients. This domain focus has been strengthened by strategic acquisitions, including Further Advisory for financial consulting and KMK Consulting to accelerate Healthcare & Life Sciences (HLS) business. The company has 5000+ employees across the San Francisco Bay Area, Chicago, Riyadh, Dubai, London, Toronto, and Bengaluru, serving top brands in Retail, CPG, TMT, Healthcare, Travel, and Industrials. For more information, please visit our website and follow us on LinkedIn.